Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
World Journal of Urology|July 11, 2014
Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intentThomas Horn, Sebastian C Schmid, Anna K Seitz, et al.
European Urology|August 11, 2014
Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre AnalysisKlaus Brasso, Frederik B Thomsen, Andres J Schrader, et al.
Plos One|January 23, 2018
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapyAnuja Sathe, Géraldine Chalaud, Immanuel Oppolzer, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Pathological Reporting of Radical Prostatectomy Specimens Following ICCR Recommendation: Impact of Electronic Reporting Tool Implementation on Quality and Interdisciplinary Communication in a Large University HospitalCaroline Richter, Eva Mezger, Peter J Schüffler, et al.
International Journal of Molecular Sciences|February 13, 2020
STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus TherapySruthi V Hindupur, Sebastian C Schmid, Jana Annika Koch, et al.
Urologia Internationalis|October 30, 2015
Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical CystectomyThomas Horn, Tina Zahel, Nathanja Adt, et al.
The Prostate|May 21, 2016
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate CancerMatthias M Heck, Mark Thalgott, Sebastian C Schmid, et al.
BMC Cancer|January 5, 2020
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)Sebastian C Schmid, Florestan J Koll, Claus Rödel, et al.
Infectious Agents and Cancer|September 23, 2015
Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational studySebastian C Schmid, Leonore Thümer, Tibor Schuster, et al.
Urologic Oncology|May 15, 2017
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatinSebastian C Schmid, Anuja Sathe, Ferdinand Guerth, et al.
Pageof 3